Latest News about Gene Therapy
Recent news which mentions Gene Therapy
   Applied Genetic's Vision Loss Gene Therapy Shows Encouraging Safety, Efficacy At Three Months
   
  May 17, 2022
  Tickers 
   AGTC
  
  
  From Benzinga
 
   Adverum Bio Posts Additional Efficacy, Safety Data From ADVM-022 Gene Therapy In Wet AMD
   
  May 02, 2022
  Tickers 
   ADVM
  
  
  From Benzinga
 
   Monitoring Board Gives Positive Recommendation On Ocugen's Eye Disease Gene Therapy Trial
   
  April 25, 2022
  Tickers 
   OCGN
  
  
  From Benzinga
 From PRUnderground
 From Benzinga
 From Benzinga
 
   Takeda Inks $2B Gene Therapy Pact With Code Biotherapeutics
   
  
  
  February 22, 2022
  From Benzinga
 
   FDA Asks For More Data To Resolve BioMarin's Gene Therapy Clinical Hold
   
  February 18, 2022
  Tickers 
   BMRN
  
  
  From Benzinga
 
   RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
   
  February 09, 2022
  Tickers 
   RGNX
  
  
  From Benzinga
 
   After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
   
  February 09, 2022
  Tickers 
   AVRO
  
  
  From Benzinga
 
   Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
   
  February 08, 2022
  Tickers 
   SGMO
  
  
  From Benzinga
 
   Sio Gene Terminates Parkinson's Gene Therapy Pact With Oxford Biomedica, Announces CEO Transition
   
  February 01, 2022
  Tickers 
   SIOX
  
  
  From Benzinga
 
   Taysha Reports Efficacy, Safety Data From High Dose Cohort For Neurological Disorder Gene Therapy Trial
   
  January 31, 2022
  Tickers 
   TSHA
  
  
  From Benzinga
 From Benzinga
 
   FDA Pushes Review Period For Bluebird bio's Neurodegenerative Disease, Thalassemia Gene Therapies
   
  January 18, 2022
  Tickers 
   BLUE
  
  
  From Benzinga
 
   Pfizer's Duchenne Gene Therapy Trial Put On FDA Hold After Patient Death
   
  December 21, 2021
  Tickers 
   PFE
  
  
  From Benzinga
 
   Adverum Outlines Development Plan For ADVM-022 Gene Therapy In Wet AMD
   
  December 21, 2021
  Tickers 
   ADVM
  
  
  From Benzinga
 
   Bluebird bio's Neurodegenerative Disease Gene Therapy Under Priority FDA Review, Despite Clinical Hold
   
  December 20, 2021
  Tickers 
   BLUE
  
  
  From Benzinga
 
   UniQure Shares Fall After Clinical Update From Huntington's Disease Gene Therapy Trial
   
  December 16, 2021
  Tickers 
   QURE
  
  
  From Benzinga
 
   New Data At ASH21 Show Bluebird's Thalassemia Gene Therapy Potentially Curative One-Time Treatment
   
  December 13, 2021
  Tickers 
   BLUE
  
  
  From Benzinga
 
   Bluebird Bio Posts Updated Data From Sickle Cell Gene Therapy Program
   
  December 13, 2021
  Tickers 
   BLUE
  
  
  From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
